ROSSARI BIOTECH LIMITED (ROSSARI)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 258.34 332.01 298.75 313.80 300.71 335.99 368.28 426.65 365.76 785.27 450.66 516.14
YOY Revenue Growth % 10.53% 37.82% 26.11% 19.03% 16.4% 1.2% 23.27% 35.96% 21.63% 133.72% 22.37% 20.97%
Other Income 1.34 1.96 2.13 1.34 1.26 1.08 1.01 2.40 1.74 3.14 1.14 22.73
Total Income 259.68 333.98 300.88 315.15 301.97 337.07 369.28 429.05 367.50 788.41 451.80 538.87
Total Expenses + 154.23 224.97 192.22 199.74 172.41 257.83 261.89 385.19 332.06 710.99 411.70 465.32
Cost of Materials Consumed 120.39 186.89 150.93 167.53 129.98 212.66 209.81 258.67 211.74 462.61 274.93 328.89
Employee Benefit Expense 13.43 12.58 14.06 11.38 14.32 13.57 16.36 15.76 15.67 32.98 18.73 17.75
Other Expenses 20.41 25.50 27.23 20.83 28.11 31.60 35.72 42.88 34.98 78.32 45.53 43.60
Operating Profit 104.12 107.04 106.53 114.06 128.29 78.16 106.39 41.46 33.70 74.28 38.96 50.82
OPM % 40.3% 32.2% 35.7% 36.3% 42.7% 23.3% 28.9% 9.7% 9.2% 9.5% 8.6% 9.8%
Profit Before Tax + 29.09 35.50 34.80 34.75 32.67 36.91 41.26 43.86 35.44 77.42 40.10 73.55
Tax Expense 7.53 9.12 9.26 8.58 8.34 9.49 10.63 11.49 9.21 19.93 9.47 18.82
Tax % 25.9% 25.7% 26.6% 24.7% 25.5% 25.7% 25.8% 26.2% 26% 25.7% 23.6% 25.6%
Profit After Tax 21.56 26.38 25.54 26.17 24.33 27.42 30.63 32.36 26.23 57.48 30.63 54.73
EPS (Basic) 3.91 4.78 4.62 4.74 4.40 4.96 5.53 5.85 4.74 10.40 5.53 9.88

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 1,431.63 1,202.91 975.17 1,072.84 690.41
YOY Revenue Growth % 19.01% 23.35% -9.1% 55.39% -
Other Income 5.74 6.77 3.60 12.70 10.21
Total Income 1,437.37 1,209.68 978.77 1,085.54 700.62
Total Expenses + 1,282.67 770.24 702.17 838.10 551.79
Cost of Materials Consumed 811.12 625.73 553.96 707.98 433.88
Employee Benefit Expense 60.01 51.46 57.35 43.53 36.66
Other Expenses 138.31 93.05 90.87 86.59 81.26
Operating Profit 148.96 432.67 273.00 234.74 138.62
OPM % 10.4% 36% 28% 21.9% 20.1%
Profit Before Exceptional 154.70 134.13 95.65 106.68 106.00
Exceptional Items 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 154.70 134.13 95.65 106.68 106.00
Tax Expense 39.96 34.49 24.26 27.21 26.90
Tax % 25.8% 25.7% 25.4% 25.5% 25.4%
Profit After Tax 114.74 99.65 71.39 79.47 79.10
EPS (Basic) 20.75 18.05 12.95 14.49 15.34

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 752.76 713.19 655.00 0.00 0.00
Property, Plant & Equipment 170.99 160.19 151.62 0.00 0.00
Capital Work in Progress 34.09 24.60 10.67 0.00 0.00
Non-Current Investments 493.11 490.60 472.78 0.00 0.00
Goodwill 1.06 1.06 1.06 0.00 0.00
Other Intangible Assets 7.15 6.04 2.76 0.00 0.00
Current Assets + 696.95 566.77 470.67 0.00 0.00
Inventories 178.83 151.13 112.83 0.00 0.00
Trade Receivables 374.60 301.91 243.85 0.00 0.00
Cash and Cash Equivalents 12.91 22.55 41.02 0.00 0.00
Current Investments 45.29 37.56 20.31 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 11.07 11.05 11.03 0.00 0.00
Other Equity 1,066.10 949.29 847.67 0.00 0.00
Non-Current Liabilities 19.43 37.69 37.06 0.00 0.00
Current Liabilities 354.32 283.14 229.91 0.00 0.00
Total Liabilities 373.75 320.83 266.97 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 92.20 73.92 113.66 33.12 0.00
Cash from Investing Activities -69.92 -69.55 -160.59 -318.12 0.00
Cash from Financing Activities -32.27 -22.09 61.21 296.91 0.00
Net Increase/Decrease in Cash -9.64 -17.95 14.28 11.91 0.00